Stratum corneum cytokine levels in mycosis fungoides.
atopic dermatitis
cutaneous T-cell lymphoma
cytokines
mycosis fungoides
tape stripping
Journal
Experimental dermatology
ISSN: 1600-0625
Titre abrégé: Exp Dermatol
Pays: Denmark
ID NLM: 9301549
Informations de publication
Date de publication:
02 2023
02 2023
Historique:
revised:
12
10
2022
received:
25
07
2022
accepted:
24
10
2022
pubmed:
28
10
2022
medline:
25
2
2023
entrez:
27
10
2022
Statut:
ppublish
Résumé
Mycosis fungoides (MF) is characterised by malignant CD4
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
214-219Informations de copyright
© 2022 The Authors. Experimental Dermatology published by John Wiley & Sons Ltd.
Références
Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105(10):3768-3785.
Durgin JS, Weiner DM, Wysocka M, Rook AH. The immunopathogenesis and immunotherapy of cutaneous T cell lymphoma: pathways and targets for immune restoration and tumor eradication. J Am Acad Dermatol. 2021;84(3):587-595.
Biedermann T, Skabytska Y, Kaesler S, Volz T. Regulation of T cell immunity in atopic dermatitis by microbes: the yin and Yang of cutaneous inflammation. Front Immunol. 2015;6:353.
Kezic S, Kammeyer A, Calkoen F, Fluhr JW, Bos JD. Natural moisturizing factor components in the stratum corneum as biomarkers of filaggrin genotype: evaluation of minimally invasive methods. Br J Dermatol. 2009;161(5):1098-1104.
Keurentjes AJ, Jakasa I, Kezic S. Research techniques made simple: stratum corneum tape stripping. J Invest Dermatol. 2021;141(5):1129-1133 e1121.
Toncic R, Kezic S, HadžavdiĆ SL, Marinovic B, Jakasa I. Stratum corneum biomarkers in atopic dermatitis: biological and spatial variability. Open Biomark J. 2020;10:47-54.
Goddard DS, Yamanaka K, Kupper TS, Jones DA. Activation of neutrophils in cutaneous T-cell lymphoma. Clin Cancer Res. 2005;11(23):8243-8249.
Mehul B, Menigot C, Fogel P, et al. Proteomic analysis of stratum corneum in cutaneous T-cell lymphomas and psoriasis. Exp Dermatol. 2019;28(3):317-321.
Hansen ER, Vejlsgaard GL, Lisby S, Heidenheim M, Baadsgaard O. Epidermal interleukin 1 alpha functional activity and interleukin 8 immunoreactivity are increased in patients with cutaneous T-cell lymphoma. J Invest Dermatol. 1991;97(5):818-823.
Pileri A, Agostinelli C, Righi S, et al. Vascular endothelial growth factor a (VEGFA) expression in mycosis fungoides. Histopathology. 2015;66(2):173-181.
Krejsgaard T, Vetter-Kauczok CS, Woetmann A, et al. Jak3- and JNK-dependent vascular endothelial growth factor expression in cutaneous T-cell lymphoma. Leukemia. 2006;20(10):1759-1766.
Miyagaki T, Sugaya M, Oka T, et al. Placental growth factor and vascular endothelial growth factor together regulate tTumor progression via increased vasculature in cutaneous T-cell lymphoma. Acta Derm Venereol. 2017;97(5):586-592.
Vacca A, Moretti S, Ribatti D, et al. Progression of mycosis fungoides is associated with changes in angiogenesis and expression of the matrix metalloproteinases 2 and 9. Eur J Cancer. 1997;33(10):1685-1692.
Rasheed H, Tolba Fawzi MM, Abdel-Halim MR, Eissa AM, Mohammed Salem N, Mahfouz S. Immunohistochemical study of the expression of matrix metalloproteinase-9 in skin lesions of mycosis fungoides. Am J Dermatopathol. 2010;32(2):162-169.
Yano S, Banno T, Walsh R, Blumenberg M. Transcriptional responses of human epidermal keratinocytes to cytokine interleukin-1. J Cell Physiol. 2008;214(1):1-13.
Kakinuma T, Sugaya M, Nakamura K, et al. Thymus and activation-regulated chemokine (TARC/CCL17) in mycosis fungoides: serum TARC levels reflect the disease activity of mycosis fungoides. J Am Acad Dermatol. 2003;48(1):23-30.
Ferenczi K, Fuhlbrigge RC, Pinkus J, Pinkus GS, Kupper TS. Increased CCR4 expression in cutaneous T cell lymphoma. J Invest Dermatol. 2002;119(6):1405-1410.